RxDoctor Payments Data

Lance Bloom

Optometrist · Boise, IDNPI 1912331877

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 35.7% of the total. 2025 is the largest year on record at $670, more than ten times the $12 reported in 2019.

$2,306in general payments, 2019–2025

Across 64 payments — averaging $36.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$824
  • Alcon$581
  • Tarsus Pharmaceuticals, Inc.$289
  • Johnson & Johnson Vision Care, Inc.$166
  • Coopervision Inc.$133
  • Kala Pharmaceuticals, Inc.$123
  • plus $190 from 3 others

What the payments were for

  • Food & beverage$2,306100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,306 in reported general payments places this provider in the 80th percentile of 304 optometrist providers in Idaho.

See all optometrist providers in Idaho

Medicare billing

Part B allowed, 2024
$21,712
Medicare patients
146
Services billed
205

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate20$638
Latanoprost53$378
Brimonidine Tartrate45$362

Paid to pharmacies, not to this prescriber.

Other optometrist in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →